Date: July 16, 2020,
Penlon is now making more ventilators in one day than the company used to deliver in 8 months. Production was ramped up by 100x than the usual capacity of Penlon, further underlining the success of the scaling up of the device.
Sunil Khurana, Group CEO BPL Medical Technologies said: “Penlon which is a 75-year-old company in the space of Critical Care, along with other members of the consortium, have done an outstanding job in completing this project in record time. During these times, it is nothing more satisfying for a Medical Devices company to help address the current challenge of Covid19 faced by entire humanity. Having completed this project, ESO2 which has received is CE certification is now available for export outside UK including India. Penlon brand assures that the product is highly reliable which is very important for “Ventilator” which is a life saving device.”
At the start of the pandemic scientific modelling predicted that the NHS was going to run out of ventilators, so the Government launched the Ventilator Challenge UK with a call to arms to automobile, aerospace manufacturers and medical device companies in the Mid-March to step up production of existing designs and re-design from the scratch.
Guru Krishnamoorthy, CEO Penlon said: “It has been humbling experience for Penlon to be a part of such a project of national importance. There is nothing more purposeful for a UK medical device company than rising to an occasion like this to save thousands of lives. We have been supported extremely well by the members and leaders of the Consortium companies, our suppliers, UK Government, and other business partners. We take this opportunity to thank each one of them. We commit ourselves to do everything required and continue to provide high quality medical devices.”
Penlon faced several challenges during the project such as sourcing large volumes of components from across different parts of the world given the lockdown implementation by several countries. Other challenges included working with several members of consortium and aligning them on production process. All of this was managed in record time to supply 11,683 units to UK Government in 15 weeks.
Ventilator Challenge UK has turned out to be a huge success as Ventilator Manufacturers in UK have ramped up their production. The Government received an overwhelming response, with over 5000 companies offering their support and over 7500 members of staff contributing to the effort.
In order to help the UK Government during the fight against Covid 19, Penlon has been one of the main contributors that has played an important role in supporting the initiative.
BPL Medical Technologies is extremely proud by the efforts put forward by all the employees at Penlon. Now these products are available to be exported outside UK and BPL Medical Technologies through its large presence in India can sell these products to help India its fight against Covid19.
” alt=”” />
This content titled BPL Medical Technologies Supplies 11,683 Emergency Ventilators to UK Government to Fight Covid19 Pandemic Through its 100 Percent Subsidiary is authored by and originally published by Business Wire India – All News
Published at : http://businesswireindia.com/RSSFeeds/NewRSS/AllNews.xml
Disclaimer: The perspectives communicated in the article/news/press release above are those of the writers’ and don’t really speak to or mirror the perspectives of this website or its personnel. Except if in any case noticed, the writer is writing in his/her own ability. They are not expected and ought not be thought to speak to legitimate thoughts, perspectives, or strategies of any individual, Institution, organization or foundation.
We are inviting Individual Blogger | News Publications | Professionals | Brands | Citizens | Kids | Youth | Social Workers to
Contact/WhatsApp: +91 7827887720 Email: email@example.com
Disclaimer: The perspectives communicated in the article/news/press release above are those of the writers’ and don’t really speak to or mirror the perspectives of this website or its personnel. Except if in any case noticed, the writer is writing in his/her own ability. They are not expected and ought not to be thought to speak to legitimate thoughts, perspectives, or strategies of any individual, Institution, organization or foundation.